Regular Article
Lithium Induces Apoptosis in Immature Cerebellar Granule Cells but Promotes Survival of Mature Neurons

https://doi.org/10.1006/excr.1994.1095Get rights and content

Abstract

Lithium (Li+) has been used in the treatment of manic—depressive disorders for several decades. More recently, Li+ has been shown to affect the signaling pathway of various neurotransmitters and growth/neurotrophic factors. We examined the effect of Li+ on the survival of cerebellar granule neurons in culture. Treatment of immature granule cells with Li+ resulted in programmed cell death (apoptosis). The death process is accompanied by DNA fragmentation, a hallmark of apoptosis. Following maturation in vitro, granule neurons are dependent on elevated concentrations of extracellular potassium ([K+]o) for survival. Lowering of [K+]o to physiological levels induces apoptosis. Surprisingly, Li+ prevents death of mature neurons caused by low [K+]o. Moreover, the concentration range at which Li+ exerts its protective effect is the same as that at which it induces apoptosis in immature neurons. Thus, a single agent under similar extracellular conditions has opposing effects on survival, depending on the developmental status of the neuron.

References (0)

Cited by (127)

  • Pyrvinium pamoate ameliorates cyclosporin A- induced hepatotoxicity via the modulation of Wnt/β-catenin signaling and upregulation of PPAR-γ

    2022, International Immunopharmacology
    Citation Excerpt :

    These findings supported the conclusions of a previous experimental investigation on a NASH model where PP decreased the hepatic FZD-7 expression. In some cells, an increased expression or stability of β-catenin has been observed to promote apoptosis [11,31]. CsA generated a considerable increase in hepatic β-catenin expression in this study, which was also seen in earlier cardiotoxicity research [65].

  • Patients receiving lithium therapy have a reduced prevalence of neurological and cardiovascular disorders

    2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    Citation Excerpt :

    A variety of evidence from in vitro and animal studies suggests that lithium has neurotrophic and cytoprotective properties. Recent research studies have reported that lithium can inhibit neuronal apoptosis (D'Mello et al., 1994; Nonaka et al., 1998), protects against neuronal death from a variety of injurious agents (Bijur et al., 2000; Centeno et al., 1998; Inouye et al., 1995; Xu et al., 2003; Zhong et al., 2006), and can enhance neuronal growth (Chen et al., 2000; Hellwey et al., 2002; Williams et al., 2004; Yasuda et al., 2009). Moreover, lithium has been demonstrated to improve brain function following brain injury.

  • Chronic lithium impairs skin tolerance to ischemia in random-pattern skin flap of rats

    2011, Journal of Surgical Research
    Citation Excerpt :

    Lithium is a mainstay for treatment of manic-depressive disorders, which was introduced into psychiatry in 1949 for the treatment of mania [4]. However, it took decades until newer properties of this drug were recognized [5, 6]. The potent biological properties of lithium in inhibiting programmed cell death attracted considerable interest to this drug in the field of reperfusion injury as well as neurodegenerative disorders such as Alzheimer's disease [7].

  • Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders

    2010, Pharmacology and Therapeutics
    Citation Excerpt :

    Although AP-1 activation may be either anti-apoptotic or pro-apoptotic depending on the nature of AP-1 binding components and the target genes induced (Karin, 1998; Mummery, 1975), it has been suggested that m3-muscarinic receptors and the DNA binding activities of AP-1 and CREB play prominent roles in regulating cell viability. Earlier pioneering studies noted that lithium promotes survival of gamma aminobutyric acid-releasing (GABAergic) neurons (Volonte et al., 1994) and mature CGCs (D'Mello et al., 1994), and accumulating evidence from various laboratories supports the view that lithium protects against diverse forms of death insults, suggesting that it is a multifunctional neuroprotectant. Glutamate-induced excitotoxicity in discrete brain areas has been implicated in a variety of neurodegenerative diseases such as stroke, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), brain trauma, cerebellar degeneration, spinal cord injury, and possibly Alzheimer's disease (AD) and Parkinson's disease (PD) (Friedlander, 2003; Mattson & Kroemer, 2003; Yuan & Yankner, 2000).

View all citing articles on Scopus
View full text